Any other company would have waited for more data

Any other company would have waited for more data before announcing trial results. I'm very excited and optimistic about the cancer possibilities but the ongoing release of results is not normal and, even with 4 patients reporting, is still anecdotal. Especially since 2 patients have only been on leronlimab for a little over a month and we have no info on what the rest of their treatment regimen has been.

I actually have a good bit of faith in Nader because just about everything he's said in the last year that I've been invested has borne out, albeit often with delays, but I can see how the constant drip of PR's can become just noise to the market.